However, semaglutide GLP-1 is often not covered if it is exclusively used for weight loss
Suzuki M, Becker L, Pritchard DK, Gharib SA, Wijsman EM, Bammler TK, Beyer RP, Vaisar T, Oram JF, Heinecke JW
Dutta, D., Nagendra, L., Harish, B., Sharma, M., Joshi, A., Hathur, B., & Kamrul-Hasan, A
MLY has research support from Abbvie, Abbott Diagnostic, BMS, Gilead, Merck and Roche diagnostics
That explanation is real and relevant, but a 2024 paper published in the Aesthetic Surgery Journal identified something that complicates and deepens this picture considerably: GLP-1 receptors have been identified on the stem cells responsible for maintaining skin health, and the research suggests these medications may directly inhibit those cells from producing collagen, elastin, and hyaluronic acid, the three structural proteins and molecules most responsible for keeping skin firm, elastic, and full